Pfizer

News

GSK chases down Pfizer in 5-in-1 meningitis jab contest

Armed with new data, GSK is preparing to file for approval of its new-generation meningitis vaccine, as it tries to maintain its leadership in the category against a chall

News

FDA advisors narrowly back Sarepta’s Duchenne gene therapy

An FDA advisory committee has given tentative backing to Sarepta’s gene therapy for Duchenne muscular dystrophy (DMD), even though the agency’s reviewers said they were no

News

Caution urged as Pfizer’s maternal RSV shot adcomm nears

There have been calls for caution when it comes to the use of Pfizer’s respiratory syncytial virus (RSV) vaccine in pregnant women, ahead of an FDA advisory committee meet

News

GSK claims first global approval for an RSV vaccine

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrat

R&D

The race for gold: Closing in on the first RSV vaccine

The industry looks set to bring the first vaccine for RSV to market in the coming year. But, which companies are leading the race, and why it would mark an important development for global health?

News

GSK’s RSV vaccine in EU pole position after CHMP backing

GSK looks set to bring the first vaccine for respiratory syncytial virus (RSV) to market in the EU, after its Arexvy shot was recommended for approval by the EMA’s human m

GSK chases down Pfizer in 5-in-1 meningitis jab contest

FDA advisors narrowly back Sarepta’s Duchenne gene therapy

Caution urged as Pfizer’s maternal RSV shot adcomm nears

GSK claims first global approval for an RSV vaccine

The race for gold: Closing in on the first RSV vaccine

GSK’s RSV vaccine in EU pole position after CHMP backing

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks